OrbusNeich Medical Group Holdings Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
David Chien
Chief executive officer
US$1.0m
Total compensation
| CEO salary percentage | 79.8% |
| CEO tenure | 8yrs |
| CEO ownership | n/a |
| Management average tenure | 5.8yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 28%
Jul 19
OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Could Be 39% Below Their Intrinsic Value Estimate
Jul 03Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?
May 28Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking
May 06OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem
Apr 25Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%
Mar 13Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down
Feb 04A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)
Oct 20Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding
Jun 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$39m |
| Mar 31 2024 | n/a | n/a | US$42m |
| Dec 31 2023 | US$1m | US$808k | US$45m |
| Sep 30 2023 | n/a | n/a | US$40m |
| Jun 30 2023 | n/a | n/a | US$36m |
| Mar 31 2023 | n/a | n/a | US$27m |
| Dec 31 2022 | US$1m | US$769k | US$18m |
| Sep 30 2022 | n/a | n/a | US$9m |
| Jun 30 2022 | n/a | n/a | US$272k |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Dec 31 2021 | US$355k | US$326k | -US$4m |
| Dec 31 2020 | US$335k | US$320k | US$7m |
| Dec 31 2019 | US$336k | US$308k | US$7m |
Compensation vs Market: David's total compensation ($USD1.01M) is above average for companies of similar size in the Hong Kong market ($USD398.33K).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
CEO
David Chien (59 yo)
8yrs
Tenure
US$1,012,000
Compensation
Mr. David Chien serves as Chairman of the Board of OrbusNeich Medical Group Holdings Limited and serves as its Chief Executive Officer since November 11, 2016. Mr. Chen has served as Director of OrbusNeic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 8yrs | US$1.01m | no data | |
| CFO, Company Secretary & Executive Director | 6.8yrs | US$569.00k | no data | |
| COO & Executive Director | 4.2yrs | US$702.00k | no data | |
| Chief Commercial Officer | 4.8yrs | no data | no data |
5.8yrs
Average Tenure
51yo
Average Age
Experienced Management: 6929's management team is seasoned and experienced (5.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 3.3yrs | US$1.01m | no data | |
| CFO, Company Secretary & Executive Director | 3.3yrs | US$569.00k | no data | |
| COO & Executive Director | 3.3yrs | US$702.00k | no data | |
| Independent Non-Executive Director | 3.2yrs | US$31.00k | no data | |
| Non-Executive Director | 3.2yrs | no data | no data | |
| Independent Non-Executive Director | 3.2yrs | US$31.00k | no data | |
| Independent Non-Executive Director | 3.2yrs | US$31.00k | no data | |
| Non-Executive Director | 3.3yrs | US$279.94k | 0.037% HK$ 1.2m | |
| Non-Executive Director | 1.5yrs | US$19.00k | no data |
3.2yrs
Average Tenure
49yo
Average Age
Experienced Board: 6929's board of directors are considered experienced (3.2 years average tenure).